First Trust Bloomberg R&D Leaders ETF (RND) Fund Overview

First Trust Bloomberg R&D Leaders ETF (RND) Financial Services Profile

The First Trust Bloomberg R&D Leaders ETF (RND) offers targeted exposure to global developed-market companies recognized for significant research and development expenditures. Employing a passive indexing strategy, the fund tracks the Bloomberg R&D Leaders Select Index, aiming to replicate its performance and provide investors with a focused allocation to innovation-driven enterprises within the financial services sector.

What Is the Investment Thesis for RND?

The First Trust Bloomberg R&D Leaders ETF (RND) provides investors with a focused, passive investment vehicle targeting companies with significant research and development expenditures. The fund's strategy to track the Bloomberg R&D Leaders Select Index, allocating a minimum of 80% of its net assets to index constituents, offers transparent exposure to innovation leaders. With a Beta of 1.24, RND exhibits higher volatility relative to the broader market, which may appeal to investors seeking growth potential tied to R&D-driven sectors. The fund's exposure to innovative companies across various sectors is a key strength, although its concentration in technology and healthcare sectors presents a potential risk if these sectors underperform. The absence of a dividend yield indicates a focus on capital appreciation from its underlying growth-oriented holdings. Investors monitor the fund's sector allocation and the performance of its top holdings for insights into its value drivers and potential returns.

Based on FMP financials and quantitative analysis

RND Key Highlights

Market Capitalization: The fund reports a Market Cap of $0.00B, which is an unusual figure that investors should note when evaluating its scale.

• Beta: With a Beta of 1.24, the fund's price movements have historically been more volatile than the overall market, indicating a higher sensitivity to market fluctuations.
• Dividend Yield: The fund currently has no dividend yield, suggesting its investment strategy is primarily focused on capital appreciation rather than income generation.
• Investment Strategy: RND employs a passive indexing investment strategy, aiming to closely track the performance of the Bloomberg R&D Leaders Select Index.
• Asset Allocation: A minimum of 80% of the fund's net assets, plus any borrowed capital for investment purposes, is committed to the securities comprising the Bloomberg R&D Leaders Select Index.

Who Are RND's Competitors?

RND is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.

AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance

What Are RND's Key Strengths?

Provides targeted exposure to innovative companies demonstrating leadership in research and development spending.

• Utilizes a passive indexing investment strategy, aiming for efficiency and consistent tracking of its benchmark index.
• Offers diversification across a basket of R&D-intensive companies within global developed markets.
• Benefits from the established brand and distribution capabilities of First Trust in the ETF market.

What Are RND's Weaknesses?

Exhibits concentration risk due to its significant allocation to technology and healthcare sectors.

• Performance is directly tied to the Bloomberg R&D Leaders Select Index, limiting active management opportunities to mitigate underperformance.
• The reported Market Cap of $0.00B suggests a very small or nascent fund, which could impact liquidity and investor interest.
• Higher Beta of 1.24 indicates greater volatility compared to the overall market, potentially leading to larger price swings.

What Are the Key Risks for RND?

**Sector Concentration Risk**: The fund's significant concentration in technology and healthcare sectors means that adverse developments or underperformance within these specific industries could disproportionately impact the fund's overall returns.

• **Index Tracking Risk**: As a passive ETF, RND aims to track its benchmark index. However, factors such as fees, expenses, and transaction costs can lead to tracking error, causing the fund's performance to deviate from that of the Bloomberg R&D Leaders Select Index.
• **Market Volatility Risk**: With a Beta of 1.24, the fund is more volatile than the broader market. This means that during periods of market downturns, RND's value could decline more significantly than the overall market.
• **Regulatory and Compliance Risk**: As an ETF in the financial services sector, RND is subject to evolving regulatory frameworks and compliance requirements, which could impact its operational costs and investment flexibility.
• **Liquidity Risk**: The reported Market Cap of $0.00B, if accurate, suggests very low assets under management, which could lead to lower trading volumes and potentially wider bid-ask spreads, impacting investor entry and exit points.

What Threats Does RND Face?

• Potential for underperformance if the technology and healthcare sectors, where the fund is concentrated, experience downturns.
• Competition from other thematic ETFs or actively managed funds offering similar exposure to innovation or growth companies.
• Changes in the methodology of the Bloomberg R&D Leaders Select Index could alter the fund's underlying holdings and risk profile.
• Broader market volatility or economic slowdowns could negatively impact the performance of its underlying global developed-market holdings.

What Are RND's Competitive Advantages?

• Proprietary Index Methodology: The fund tracks the Bloomberg R&D Leaders Select Index, which utilizes a specific methodology to identify and weight companies based on their R&D expenditure, offering a unique thematic focus.
• First Trust Brand Recognition: As part of the First Trust family of ETFs, RND benefits from an established brand, distribution network, and investor trust within the asset management industry.
• Specialized Thematic Focus: Its distinct focus on R&D leaders provides a niche exposure that differentiates it from broader market or sector-specific ETFs, appealing to investors seeking targeted innovation exposure.
• Operational Efficiency of Passive Management: The passive indexing strategy minimizes management intervention and associated costs, potentially offering a more cost-effective solution compared to actively managed funds with similar objectives.

What Does RND Do?

The First Trust Bloomberg R&D Leaders ETF (RND) is an exchange-traded fund structured to closely track the overall performance, encompassing both capital appreciation and income, of the Bloomberg R&D Leaders Select Index. The Fund operates under a passive indexing investment strategy, committing a minimum of 80% of its net assets, including any borrowed capital for investment purposes, to the securities that constitute its benchmark Index. This strategic allocation ensures a high degree of correlation with the Index's performance. The primary objective of the Fund is to mirror the total return of the Bloomberg R&D Leaders Select Index, which comprehensively accounts for dividends distributed by its underlying holdings, prior to the deduction of the Fund's operating fees and expenses. This approach positions RND as a vehicle for investors seeking exposure to companies that are leaders in research and development spending, thereby tapping into innovation-driven growth across various sectors. Headquartered in Wheaton, US, the Fund provides a structured way to invest in global developed-market companies identified by their substantial R&D investments, offering a diversified basket of such enterprises. Its design caters to institutional and retail investors looking for a systematic and cost-effective method to access companies at the forefront of innovation, without engaging in active stock selection.

What Products and Services Does RND Offer?

• Tracks the overall performance of the Bloomberg R&D Leaders Select Index.
• Employs a passive indexing investment strategy.
• Commits a minimum of 80% of its net assets to the securities constituting the Index.
• Aims to mirror the total return of the Index, including dividends from underlying holdings.
• Invests in global developed-market companies demonstrating leadership in R&D spending.
• Provides investors with exposure to innovation-driven companies.
• Operates as an exchange-traded fund (ETF) within the financial services sector.

How Does RND Make Money?

• Generates revenue through management fees charged to investors for tracking the Bloomberg R&D Leaders Select Index.
• Manages a portfolio of R&D-intensive companies selected according to the Index's methodology.
• Offers a transparent and liquid investment vehicle for passive exposure to a specific thematic investment strategy.
• Aims to achieve its investment objective by replicating the performance of its benchmark index, rather than active stock selection.

What Industry Does RND Operate In?

The First Trust Bloomberg R&D Leaders ETF operates within the dynamic asset management industry, specifically leveraging the growing trend of thematic and passive investing. The broader financial services sector has seen a significant shift towards exchange-traded funds (ETFs) due to their transparency, lower expense ratios, and ease of trading. RND positions itself within this landscape by offering targeted exposure to a specific investment theme: companies demonstrating leadership in research and development. This aligns with a market trend where investors increasingly seek specialized exposure to growth drivers like innovation. While the asset management industry is highly competitive, RND differentiates itself through its unique index methodology, focusing on R&D expenditure as a key weighting factor. The fund's passive strategy aims to capture market returns efficiently within this niche, contrasting with actively managed funds that rely on manager discretion.

Who Are RND's Key Customers?

• Institutional investors seeking thematic exposure to R&D leaders.
• Financial advisors building diversified portfolios with a focus on innovation.
• Retail investors looking for a convenient way to invest in companies with high R&D expenditures.
• Investors who prefer passive investment strategies for cost-efficiency and index tracking.

RND Financials

RND Latest News

RND Analyst Consensus

RND MoonshotScore

Common Questions About RND (Financials)

Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.

Official Resources